A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

434

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

May 31, 2003

Conditions

Bipolar Disorder

Interventions

DRUG

Topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00037674 - A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder | Biotech Hunter | Biotech Hunter